Direxion Daily S&P Biotech Bear 3X ETF (LABD) closed at $8.96 on October 16, 2026, up 11.3% from the previous close, on volume of 29,959,191 shares (30-day average 22,807,201).
Data as of October 16, 2026.
16-Oct-2026
No press releases found.
Bullish On LABD? You Might Want To Consider This Credit Put Spread Expiring in 15 Days
Market Chameleon (Thu, 10-Apr 9:51 AM ET)
The Direxion Daily S&P Biotech Bear 3X ETF (the "Fund") seeks daily inverse leveraged (-3X) investment results and is very different from most other exchange-traded funds. As a result, the Fund may be riskier than alternatives that do not use leverage because the Fund's objective is to magnify the daily inverse performance of the S&P Biotechnology Select Industry Index (the "Index"). The return for investors that invest for periods longer or shorter than a trading day should not be expected to be -300% of the performance of the Index for the period. The Index is provided by S&P Dow Jones Indices (the "Index Provider") and includes domestic companies from the biotechnology industry. The Index is a modified equal- weighted index that is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS").
Direxion Daily S&P Biotech Bear 3X ETF trades on the ARCA stock market under the symbol LABD.
As of October 16, 2026, LABD stock price climbed to $8.96 with 29,959,191 million shares trading.
LABD has a beta of -2.88, meaning it tends to be less sensitive to market movements. LABD has a correlation of 0.20 to the broad based SPY ETF.
LABD has a market cap of $71.29 million. This is considered a Micro Cap stock.
In the last 3 years, LABD traded as high as $299.20 and as low as $5.81.
LABD has underperformed the market in the last year with a return of -70.7%, while SPY returned +16.7%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in LABD shares. However, LABD has outperformed the market in the last 3 month and 2 week periods, returning +5.1% and +19.6%, while SPY returned +1.9% and -0.8%, respectively. This indicates LABD has been having a stronger performance recently.
LABD support price is $7.59 and resistance is $8.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABD shares will trade within this expected range on the day.
